UB
DNTH icon

UMB Bank’s Dianthus Therapeutics DNTH Stock Holding History

UMB Bank’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46
Closed -$562 – 1703
2023
Q2 		$562 Hold
46
– – ﹤0.01% 1625
2023
Q1 		$590 Hold
46
– – ﹤0.01% 1636
2022
Q4 		$0 Hold
46
– – ﹤0.01% 1742
2022
Q3 		$1K Hold
46
– – ﹤0.01% 1654
2022
Q2 		$1K Hold
46
– – ﹤0.01% 1815
2022
Q1 		$2K Buy
+46
New +$2.51K ﹤0.01% 1807

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

UMB Bank's DNTH Position: Q3 2023 in Review

UMB Bank sold out of Dianthus Therapeutics (DNTH) in Q3 2023, closing a stake of 46 shares — an estimated $562 sold.

UMB Bank first reported a position in DNTH in Q1 2022 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 30 funds tracked by Wall St. Rank hold DNTH as of Q3 2023.

  • UMB Bank reported no remaining Dianthus Therapeutics position as of Q3 2023 after selling out during the quarter.
  • UMB Bank sold 46 Dianthus Therapeutics shares in Q3 2023, an estimated $562.
  • UMB Bank first reported a position in Dianthus Therapeutics in Q1 2022 and held it in 6 quarters.
  • UMB Bank's Dianthus Therapeutics position peaked at $2K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2023.

Based on UMB Bank's 13F filing for Q3 2023, filed 18 Oct 2023.